Realizing the Dream of Precision Medicine for Neurodegenerative Diseases
Rewiring the fight against degenerative brain diseases
Our Great Challenge
An estimated 80 million people worldwide live with a degenerative brain disease. That number is expected to rise rapidly over the coming decades as populations age, lifespans increase and exposures to environmental toxins rise. The burden of trying to care for all those individuals will put an immense strain on our economies and test the social fabric of human civilization.
Currently, there are no medicines that can slow, much less stop, degenerative brain diseases. This is because for decades neurology has assumed that what we see in the clinic will match nicely onto something we can measure in biology, leading us to believe that diseases like Parkinson’s, Alzheimer’s, ALS, etc. each have a unique biology that we can find and target.
It is time for a new way of thinking that embraces the idea that there are likely dozens of biological pathways that lead to these diseases and that we must find and target each separately if we are ever going to get therapies that can alter these diseases.
That is the mission of the CCBP.